SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: VLAD who wrote (11010)7/9/1998 6:42:00 PM
From: AlienTech  Read Replies (1) of 23519
 
>>''In recent months the erectile dysfunction market has made a major shift toward the primary care physician (PCP). This shift has necessitated a change in VIVUS' strategy and the decision to partner in the U.S. with a large pharmaceutical company. The success of VIVUS' partners in launching MUSE worldwide has demonstrated the benefits of being a well-known presence in the marketplace,'' said Leland Wilson, President and CEO of VIVUS, Inc. ''Our strategy change also has the immediate benefit to VIVUS of reducing expenses and poising the Company for a return to profitability.'' <<

This guys sharp. It took him this long to figure this out. But maybe its never too late.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News